{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Streptococcus Erythromycin",
        "VITEK\u00ae 2 AST-ST Erythromycin"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K111976",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063597"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "January 25, 2012",
    "Summary Letter Received Date": "January 27, 2012",
    "Submission Date": "July 1, 2011",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Erythromycin"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2 System",
        "VITEK\u00ae 2 Compact System"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Automated microdilution",
        "Minimum inhibitory concentration (MIC) determination"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated susceptibility testing"
    ],
    "Submission Type(s)": [
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Streptococcus Erythromycin reagent card for automated antimicrobial susceptibility testing using the VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems.",
    "Indications for Use Summary": "Quantitative test for determination of in vitro susceptibility of Streptococcus species to erythromycin, used with VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems as a laboratory aid.",
    "fda_folder": "Microbiology"
}